These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30648835)

  • 1. Moderate to severe psoriasis: a single-center analysis of gender prevalence.
    Odorici G; Paganelli A; Peccerillo F; Serra J; Chester J; Kaleci S; Pellacani G; Conti A
    Ital J Dermatol Venerol; 2021 Apr; 156(2):226-230. PubMed ID: 30648835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
    Feldman SR; Zhao Y; Shi L; Tran MH
    J Manag Care Spec Pharm; 2015 Oct; 21(10):874-88. PubMed ID: 26402388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.
    Yeung H; Takeshita J; Mehta NN; Kimmel SE; Ogdie A; Margolis DJ; Shin DB; Attor R; Troxel AB; Gelfand JM
    JAMA Dermatol; 2013 Oct; 149(10):1173-9. PubMed ID: 23925466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
    Benzian-Olsson N; Dand N; Chaloner C; Bata-Csorgo Z; Borroni R; Burden AD; Cooper HL; Cornelius V; Cro S; Dasandi T; Griffiths CEM; Kingo K; Koks S; Lachmann H; McAteer H; Meynell F; Mrowietz U; Parslew R; Patel P; Pink AE; Reynolds NJ; Tanew A; Torz K; Trattner H; Wahie S; Warren RB; Wright A; Barker JN; Navarini AA; Smith CH; Capon F;
    JAMA Dermatol; 2020 Nov; 156(11):1216-1222. PubMed ID: 32936291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study.
    Paschoal RS; Silva DA; Cardili RN; Souza CDS
    An Bras Dermatol; 2018 Mar; 93(2):222-228. PubMed ID: 29723366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities in patients with palmoplantar plaque psoriasis.
    Greenberg R; Goldsmith T; Zeltser D; Shapira I; Berliner S; Rogowski O; Shenhar-Tsarfaty S; Sprecher E; Matz H
    J Am Acad Dermatol; 2021 Mar; 84(3):639-643. PubMed ID: 32811679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China.
    Ma L; Li M; Wang H; Li Y; Bai B
    Arch Dermatol Res; 2014 Apr; 306(3):247-51. PubMed ID: 24385235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidities and cardiovascular risk factors in patients with psoriasis.
    Baeta IG; Bittencourt FV; Gontijo B; Goulart EM
    An Bras Dermatol; 2014; 89(5):735-44. PubMed ID: 25184912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain.
    Fernández-Torres RM; Pita-Fernández S; Fonseca E
    Int J Dermatol; 2014 Nov; 53(11):e507-11. PubMed ID: 25266080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach.
    Duarte GV; Oliveira MF; Follador I; Silva TS; Carvalho EM
    An Bras Dermatol; 2016; 91(6):743-747. PubMed ID: 28099594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis: a cross-sectional study (Arizona study).
    Sanchez-Carazo JL; López-Estebaranz JL; Guisado C
    J Dermatol; 2014 Aug; 41(8):673-8. PubMed ID: 24942203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study.
    Itani S; Arabi A; Harb D; Hamzeh D; Kibbi AG
    Int J Dermatol; 2016 Apr; 55(4):390-5. PubMed ID: 26748974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in Moroccan patients with psoriasis.
    Meziane M; Kelati A; Najdi A; Berraho A; Nejjari C; Mernissi FZ
    Int J Dermatol; 2016 Apr; 55(4):396-400. PubMed ID: 26712557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.
    Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V
    Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Claims Analyses of Comorbidity Burden, Treatment Pattern, Healthcare Resource Utilization, and Costs in Pediatric Psoriasis.
    Edson-Heredia E; Anderson S; Guo J; Zhu B; Malatestinic WN; Wine-Lee L; Swanson E
    Adv Ther; 2021 Jul; 38(7):3948-3961. PubMed ID: 34091866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients.
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    Am J Clin Dermatol; 2017 Aug; 18(4):583-590. PubMed ID: 28342016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.
    Carrascosa JM; Vilavella M; Garcia-Doval I; Carretero G; Vanaclocha F; Daudén E; Gómez-García FJ; Herrera-Ceballos E; De la Cueva Dobao P; Belinchón I; Sánchez-Carazo JL; Alsina M; López-Estebaranz JL; Ferrán M; Peral F; Torrado R; Rivera R; Jiménez-Puya R; Mendiola MV; Ferrándiz C;
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):907-14. PubMed ID: 23848131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials.
    Wan MT; Torigian DA; Alavi A; Alvarez J; Chiesa Fuxench ZC; Noe MH; Papadopoulos M; Shin DB; Takeshita J; Werner TJ; Mehta NN; Gelfand JM
    J Am Acad Dermatol; 2019 Jun; 80(6):1630-1639. PubMed ID: 30654078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between moderate to severe psoriasis and periodontitis in a Scandinavian population.
    Skudutyte-Rysstad R; Slevolden EM; Hansen BF; Sandvik L; Preus HR
    BMC Oral Health; 2014 Nov; 14():139. PubMed ID: 25427764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.